Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Lucid Diagnostics stock
Learn how to easily invest in Lucid Diagnostics stock.
Lucid Diagnostics is a medical devices business based in the US. Lucid Diagnostics shares (LUCD) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy Lucid Diagnostics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LUCD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Lucid Diagnostics stock price (NASDAQ: LUCD)
Use our graph to track the performance of LUCD stocks over time.Lucid Diagnostics shares at a glance
Information last updated 2023-03-20.
| Latest market close | $1.61 |
|---|---|
| 52-week range | $1.11 - $3.64 |
| 50-day moving average | $1.37 |
| 200-day moving average | $1.93 |
| Wall St. target price | $5.22 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.48 |
Buy Lucid Diagnostics stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 7 of 7
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Lucid Diagnostics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lucid Diagnostics price performance over time
Historical closes compared with the close of $1.61 from 2023-03-20
| 1 week (2023-03-14) | -6.40% |
|---|---|
| 1 month (2023-02-21) | 21.97% |
| 3 months (2022-12-21) | 3.87% |
| 6 months (2022-09-21) | -5.85% |
| 1 year (2022-03-21) | -44.77% |
|---|---|
| 2 years (2021-03-17) | N/A |
| 3 years (2020-03-17) | N/A |
| 5 years (2018-03-17) | N/A |
Lucid Diagnostics financials
| Revenue TTM | $377,000 |
|---|---|
| Gross profit TTM | $-3,237,000 |
| Return on assets TTM | -76.73% |
| Return on equity TTM | -144.42% |
| Profit margin | 0% |
| Book value | $0.57 |
| Market capitalisation | $74.6 million |
TTM: trailing 12 months
Lucid Diagnostics share dividends
We're not expecting Lucid Diagnostics to pay a dividend over the next 12 months.
You may also wish to consider:
- Quest Diagnostics Incorporated (DGX.US) (2.13% forward annual dividend yield)
- Laboratory Corporation of America (LH.US) (1.31% forward annual dividend yield)
Lucid Diagnostics overview
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Lucid Diagnostics in the news
PAVmed Inc. (NASDAQ:PAVM) Q4 2022 Earnings Call Transcript
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2022 Earnings Call Transcript
Q4 2022 PAVmed Inc Earnings Call
Frequently asked questions
What percentage of Lucid Diagnostics is owned by insiders or institutions?Currently 77.056% of Lucid Diagnostics shares are held by insiders and 4.422% by institutions. When does the fiscal year end for Lucid Diagnostics?
Lucid Diagnostics's fiscal year ends in December. Where is Lucid Diagnostics based?
Lucid Diagnostics's address is: One Grand Central Place, New York, NY, United States, 10165 What is Lucid Diagnostics's ISIN number?
Lucid Diagnostics's international securities identification number is: US54948X1090
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert